Precision Medicine And AI Discovery Will Fuel Global Immuno-Oncology Demand
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
08 Jul 25
Updated
20 Aug 25
AnalystHighTarget's Fair Value
US$13.00
88.8% undervalued intrinsic discount20 Aug
US$1.45
1Y
-29.3%7D
-6.5%